Find investors
← Back to all investors
NW
ResearchedAngel Investors

Nicholas Walrod

Managing Director

Angel InvestorsSeed Round
Pitch Nicholas

Get their honest, personalized take on your startup.

Sign in to pitch Nicholas

At a glance

Full Name
Nicholas Walrod
Title
Managing Partner
Firm
American Century Private Investments, American Century Investments
Firm Type
Venture capital / private investments team within an asset-management firm
Investment Stage
Early-stage venture capital
Target Company Profile
Companies with breakthrough innovations addressing healthcare or environmental problems
Sector Focus
Healthcare, medical devices, diagnostics, biopharmaceuticals, drug delivery, life-science tools, clean energy, water, green chemistry and materials, agriculture and food, waste reduction

Background

Nicholas Walrod is a managing partner at American Century Investments, where he specializes in private equity investing. American Century lists his firm start date as 2023 and his financial-services industry start date as 1999.

Before joining American Century, Walrod was a managing partner and co-founder of 3x5 Partners. American Century describes its Private Investments team as the former 3x5 Partners team, now backed by American Century’s platform. Before 3x5 Partners, Walrod was an alternatives investment analyst at Arnerich Massena.

Walrod received a bachelor’s degree from Duke University. His current team says it had worked together for several years before joining American Century in 2023, and positions its work around early-stage companies with breakthrough ideas in healthcare and the environment.

Investment Thesis & Focus

  • American Century Private Investments’ stated headline is: “Invest in what the world needs.”
  • The team seeks venture investments in “solutions focused [on] solving real world problems and improving human and environmental health.”
  • Sector focus is explicitly split between healthcare and environment. Healthcare areas include medical devices, diagnostics, biopharmaceuticals, drug delivery, and life-science tools.
  • Environmental focus areas include clean energy, water, green chemistry and materials, agriculture and food, and waste reduction.
  • The team looks for “breakthrough innovations” in healthcare or the environment and emphasizes large markets tied to human well-being.
  • American Century’s 2024 venture-capital outlook argued that weak market conditions had improved investor negotiating leverage, especially in healthcare and climate initiatives.
  • American Century’s 2025 human-needs thesis argued that climate and healthcare startups face underinvestment, creating opportunity for private capital where companies address human wellness.

Notable Investments

  • Aquea Health - Developing next-generation minimally invasive glaucoma surgery technology.
  • Arch Oncology - Developing anti-CD47 antibodies intended to block cancer growth more efficiently.
  • Bonum Therapeutics - Therapeutics company spun out of Good Therapeutics, using allosteric regulation to create more active and less toxic medicines.
  • Claros Technologies - Developing PFAS water-pollution capture, concentration, destruction, and monitoring technology.
  • ENZINC - Developing zinc battery technology for scaled energy storage.
  • Fervo Energy - Developer, owner, and operator of next-generation geothermal energy technologies.
  • Good Therapeutics - Developing context-dependent protein therapeutics designed to reduce systemic toxicity.
  • InterVene - Developing therapy for chronic venous insufficiency from deep vein reflux.
  • Koya Medical - Treating lymphedema with a compression medical device that supports patient mobility.
  • Rivermark Medical - Developing a minimally invasive treatment for benign prostatic hyperplasia.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.